A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study evaluated the safety and efficacy of once and twice daily TD-4208 and placebo when
administered using a jet nebulizer for 7 days in a cross-over design to patients with
moderate to severe chronic obstructive pulmonary disease.